Application | Comment | Organism |
---|---|---|
medicine | potential of the enzyme as a critical target for drug development against Chagas disease. The enzyme is absent in mammalian host, suggesting that inhibition of proline racemase may have therapeutic potential | Trypanosoma cruzi |
medicine | potential of the enzyme as a critical target for drug development against Chagas disease. The enzyme is absent in mammalian host, suggesting that inhibition of proline racemase may have therapeutic potential | Trypanosoma cruzi |
Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli | Trypanosoma cruzi |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
pyrrole-2-carboxylic acid | - |
Trypanosoma cruzi |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
29 | - |
L-proline | pH 6.0, 37°C | Trypanosoma cruzi | |
75 | - |
L-proline | pH 6.0, 37°C | Trypanosoma cruzi |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
extracellular | membrane-bound and secreted forms of enzyme are present upon differentiation of the parasite into non-dividing infective forms | Trypanosoma cruzi | - |
- |
intracellular | in replicative non-infective forms of Trypanosoma cruzi | Trypanosoma cruzi | 5622 | - |
membrane | membrane-bound and secreted forms of enzyme are present upon differentiation of the parasite into non-dividing infective forms | Trypanosoma cruzi | 16020 | - |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
40100 | - |
2 * 40100, TcPRACB, SDS-PAGE | Trypanosoma cruzi |
45800 | - |
2 * 45800, TcPRACA, SDS-PAGE | Trypanosoma cruzi |
80000 | - |
TCPRACA, gel filtration, non-denaturing PAGE | Trypanosoma cruzi |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Trypanosoma cruzi | Q4DA80 | - |
- |
Trypanosoma cruzi | Q868H8 | - |
- |
Storage Stability | Organism |
---|---|
-20°C, 50% glycerol or diluted in sodium acetate buffer, pH 6.0, activity is impaired | Trypanosoma cruzi |
-20°C, 50% glycerol or diluted in sodium acetate buffer, pH 6.0, stable | Trypanosoma cruzi |
-20°C, as ammonium sulfate precipitate, stable | Trypanosoma cruzi |
23°C, 0.5 M imidazole buffer, pH 8.0, 10 days, TcPRACA loses 84% of its activity | Trypanosoma cruzi |
23°C, 0.5 M imidazole buffer, pH 8.0, 10 days, TcPRACB is stable, TcPRACA loses 84% of its activity | Trypanosoma cruzi |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-proline | - |
Trypanosoma cruzi | D-proline | - |
? | |
additional information | TcPRACB: no reaction with L-hydroxyproline | Trypanosoma cruzi | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | 2 * 40100, TcPRACB, SDS-PAGE | Trypanosoma cruzi |
dimer | 2 * 45800, TcPRACA, SDS-PAGE | Trypanosoma cruzi |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
- |
Trypanosoma cruzi |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
80 | - |
5 min, activity is abolished | Trypanosoma cruzi |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
4.5 | 8.5 | - |
Trypanosoma cruzi |
5.5 | 7 | - |
Trypanosoma cruzi |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
additional information | TcPRACB is a cofactor-independent racemase | Trypanosoma cruzi |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0036 | - |
pyrrole-2-carboxylic acid | pH 6.0, 37°C, TcPRACB | Trypanosoma cruzi | |
0.0057 | - |
pyrrole-2-carboxylic acid | pH 6.0, 37°C, TcPRACA | Trypanosoma cruzi |